ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
This Quarter Return
-18.95%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(-61%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-77.75%
Top 10 Holdings %
Top 10 Hldgs %
20.06%
Holding
595
New
108
Increased
266
Reduced
153
Closed
46
Top Buys
| 1 |
Vanguard Information Technology ETF
VGT
|
$2.43M |
| 2 |
Coca-Cola
KO
|
$1.96M |
| 3 |
Bristol-Myers Squibb
BMY
|
$1.66M |
| 4 |
Verizon
VZ
|
$1.65M |
| 5 |
Colgate-Palmolive
CL
|
$1.56M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$21.5M |
| 2 |
Gilead Sciences
GILD
|
$14.4M |
| 3 |
Nucor
NUE
|
$12.8M |
| 4 |
Franklin Resources
BEN
|
$12.4M |
| 5 |
Bath & Body Works
BBWI
|
$12M |
Sector Composition
| 1 | Real Estate | 18.72% |
| 2 | Healthcare | 14.49% |
| 3 | Technology | 12.76% |
| 4 | Consumer Staples | 12.63% |
| 5 | Consumer Discretionary | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Integra LifeSciences
IART
$1.18B
| $144K | 0.08% |
3,220
+1,690
| +110% | +$75.6K |
|
227
Boston Scientific
BSX
$159B
| $143K | 0.08% |
4,378
+2,115
| +93% | +$69.1K |
|
|
CSII
228
DELISTED
Cardiovascular Systems, Inc.
CSII
| $141K | 0.08% |
4,001
+1,981
| +98% | +$69.8K |
|
229
NeoGenomics
NEO
$1.06B
| $140K | 0.08% |
5,083
+1,792
| +54% | +$49.4K |
|
230
Axogen
AXGN
$718M
| $140K | 0.08% |
13,450
+7,738
| +135% | +$80.5K |
|
|
MTLS
231
Materialise
MTLS
$291M
| $137K | 0.07% |
7,362
+3,526
| +92% | +$65.6K |
|
|
VCRA
232
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $134K | 0.07% |
6,291
+2,006
| +47% | +$42.7K |
|
233
Exact Sciences
EXAS
$9.33B
| $133K | 0.07% |
2,301
+1,239
| +117% | +$71.6K |
|
234
Bio-Rad Laboratories Class A
BIO
$7.8B
| $133K | 0.07% |
378
+150
| +66% | +$52.8K |
|
235
Charles River Laboratories
CRL
$7.99B
| $131K | 0.07% |
1,034
+383
| +59% | +$48.5K |
|
|
NUAN
236
DELISTED
Nuance Communications, Inc.
NUAN
| $128K | 0.07% |
7,636
+3,644
| +91% | +$61.1K |
|
237
Vertex Pharmaceuticals
VRTX
$102B
| $126K | 0.07% |
529
+101
| +24% | +$24.1K |
|
238
iRhythm Technologies
IRTC
$5.67B
| $126K | 0.07% |
1,543
+297
| +24% | +$24.3K |
|
|
B
239
Barrick Mining Corporation
B
$46.3B
| $126K | 0.07% |
6,893
+2,241
| +48% | +$41K |
|
240
Glaukos
GKOS
$5.42B
| $126K | 0.07% |
4,068
+2,481
| +156% | +$76.8K |
|
241
Natera
NTRA
$23B
| $125K | 0.07% |
4,196
+1,603
| +62% | +$47.8K |
|
|
BEAT
242
DELISTED
BioTelemetry, Inc.
BEAT
| $124K | 0.07% |
3,219
+1,532
| +91% | +$59K |
|
243
Methanex
MEOH
$2.73B
| $123K | 0.07% |
10,206
| – | – |
|
244
Revvity
RVTY
$9.68B
| $122K | 0.07% |
1,624
+748
| +85% | +$56.2K |
|
245
IQVIA
IQV
$31.4B
| $116K | 0.06% |
1,075
+492
| +84% | +$53.1K |
|
246
Energy Fuels
UUUU
$2.64B
| $114K | 0.06% |
96,960
+36,100
| +59% | +$42.4K |
|
247
Omnicell
OMCL
$1.51B
| $114K | 0.06% |
1,743
+692
| +66% | +$45.3K |
|
248
NovoCure
NVCR
$1.35B
| $113K | 0.06% |
1,674
+1,103
| +193% | +$74.5K |
|
249
Codexis
CDXS
$218M
| $113K | 0.06% |
10,120
+6,075
| +150% | +$67.8K |
|
250
Denison Mines
DNN
$2.11B
| $111K | 0.06% |
440,100
+193,844
| +79% | +$48.9K |
|